HCA Healthcare Inc.
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory t… Read more
HCA Healthcare Inc. (0J1R) - Net Assets
Latest net assets as of December 2025: $-2.77 Billion USD
Based on the latest financial reports, HCA Healthcare Inc. (0J1R) has net assets worth $-2.77 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($60.72 Billion) and total liabilities ($63.49 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.77 Billion |
| % of Total Assets | -4.56% |
| Annual Growth Rate | N/A |
| 5-Year Change | -286.1% |
| 10-Year Change | N/A |
| Growth Volatility | 290.01 |
HCA Healthcare Inc. - Net Assets Trend (1990–2025)
This chart illustrates how HCA Healthcare Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for HCA Healthcare Inc. (1990–2025)
The table below shows the annual net assets of HCA Healthcare Inc. from 1990 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-2.77 Billion | -599.28% |
| 2024-12-31 | $555.00 Million | -47.64% |
| 2023-12-31 | $1.06 Billion | +1552.05% |
| 2022-12-31 | $-73.00 Million | -104.90% |
| 2021-12-31 | $1.49 Billion | -48.51% |
| 2020-12-31 | $2.89 Billion | +611.86% |
| 2019-12-31 | $-565.00 Million | +80.64% |
| 2018-12-31 | $-2.92 Billion | +41.58% |
| 2017-12-31 | $-5.00 Billion | +11.33% |
| 2016-12-31 | $-5.63 Billion | +6.83% |
| 2015-12-31 | $-6.05 Billion | +6.96% |
| 2014-12-31 | $-6.50 Billion | +6.21% |
| 2013-12-31 | $-6.93 Billion | +16.94% |
| 2012-12-31 | $-8.34 Billion | -18.92% |
| 2011-12-31 | $-7.01 Billion | +35.02% |
| 2010-12-31 | $-10.79 Billion | -35.30% |
| 2009-12-31 | $-7.98 Billion | +13.84% |
| 2008-12-31 | $-9.26 Billion | +3.54% |
| 2007-12-31 | $-9.60 Billion | +8.28% |
| 2006-12-31 | $-10.47 Billion | -283.92% |
| 2005-12-31 | $5.69 Billion | +9.11% |
| 2004-12-31 | $5.22 Billion | -24.29% |
| 2003-12-31 | $6.89 Billion | +9.12% |
| 2002-12-31 | $6.31 Billion | +18.55% |
| 2001-12-31 | $5.33 Billion | +6.99% |
| 2000-12-31 | $4.98 Billion | -21.99% |
| 1999-12-31 | $6.38 Billion | -23.56% |
| 1998-12-31 | $8.35 Billion | +3.22% |
| 1997-12-31 | $8.09 Billion | -14.39% |
| 1996-12-31 | $9.45 Billion | +20.30% |
| 1995-12-31 | $7.85 Billion | +48.69% |
| 1994-12-31 | $5.28 Billion | +49.66% |
| 1993-12-31 | $3.53 Billion | +1091.49% |
| 1992-12-31 | $296.10 Million | +109.55% |
| 1991-12-31 | $141.30 Million | +147.46% |
| 1990-12-31 | $57.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to HCA Healthcare Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Total Equity | $-6.03 Billion | 100.00% |
HCA Healthcare Inc. Competitors by Market Cap
The table below lists competitors of HCA Healthcare Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MercadoLibre Inc.
NASDAQ:MELI
|
$81.29 Billion |
|
PNC Financial Services Group Inc
NYSE:PNC
|
$81.63 Billion |
|
Banco Bilbao Vizcaya Argentaria S.A
PINK:BBVXF
|
$81.72 Billion |
|
Synopsys Inc
NASDAQ:SNPS
|
$81.78 Billion |
|
Freeport-McMoRan Inc.
LSE:0R2O
|
$81.03 Billion |
|
Bank of New York Mellon Corp.
LSE:0HLQ
|
$80.52 Billion |
|
U.S. Bancorp
NYSE:USB
|
$79.95 Billion |
|
Alphabet Inc Class A CEDEAR
BA:GOOGL
|
$79.67 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in HCA Healthcare Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -2,499,000,000 to -6,027,000,000, a change of -3,528,000,000.
- Net income of 6,784,000,000 contributed positively to equity growth.
- Dividend payments of 679,000,000 reduced retained earnings.
- Share repurchases of 10,067,000,000 reduced equity.
- Other comprehensive income increased equity by 387,000,000.
- Other factors increased equity by 47,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $6.78 Billion | +112.56% |
| Dividends Paid | $679.00 Million | -11.27% |
| Share Repurchases | $10.07 Billion | -167.03% |
| Other Comprehensive Income | $387.00 Million | +6.42% |
| Other Changes | $47.00 Million | +0.78% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares HCA Healthcare Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1990-12-31 | $2.32 | $513.79 | x |
| 1991-12-31 | $4.74 | $513.79 | x |
| 1992-12-31 | $8.09 | $513.79 | x |
| 1993-12-31 | $7.05 | $513.79 | x |
| 1994-12-31 | $9.72 | $513.79 | x |
| 1995-12-31 | $10.61 | $513.79 | x |
| 1996-12-31 | $12.70 | $513.79 | x |
| 1997-12-31 | $10.93 | $513.79 | x |
| 1998-12-31 | $11.75 | $513.79 | x |
| 1999-12-31 | $8.43 | $513.79 | x |
| 2000-12-31 | $7.95 | $513.79 | x |
| 2001-12-31 | $8.87 | $513.79 | x |
| 2002-12-31 | $10.88 | $513.79 | x |
| 2003-12-31 | $12.17 | $513.79 | x |
| 2004-12-31 | $9.11 | $513.79 | x |
| 2005-12-31 | $10.87 | $513.79 | x |
| 2006-12-31 | $-27.73 | $513.79 | x |
| 2007-12-31 | $-30.22 | $513.79 | x |
| 2008-12-31 | $-29.41 | $513.79 | x |
| 2009-12-31 | $-25.77 | $513.79 | x |
| 2010-12-31 | $-27.27 | $513.79 | x |
| 2011-12-31 | $-16.65 | $513.79 | x |
| 2012-12-31 | $-21.03 | $513.79 | x |
| 2013-12-31 | $-17.90 | $513.79 | x |
| 2014-12-31 | $-17.53 | $513.79 | x |
| 2015-12-31 | $-17.81 | $513.79 | x |
| 2016-12-31 | $-18.45 | $513.79 | x |
| 2017-12-31 | $-18.28 | $513.79 | x |
| 2018-12-31 | $-13.93 | $513.79 | x |
| 2019-12-31 | $-8.06 | $513.79 | x |
| 2020-12-31 | $1.66 | $513.79 | x |
| 2021-12-31 | $-2.84 | $513.79 | x |
| 2022-12-31 | $-9.39 | $513.79 | x |
| 2023-12-31 | $-6.42 | $513.79 | x |
| 2024-12-31 | $-9.55 | $513.79 | x |
| 2025-12-31 | $-26.12 | $513.79 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently HCA Healthcare Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.97%
- • Asset Turnover: 1.25x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (24.85%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1990 | 23.67% | 3.60% | 0.85x | 7.77x | $5.66 Million |
| 1991 | 12.86% | 3.30% | 0.95x | 4.11x | $3.38 Million |
| 1992 | 9.64% | 3.35% | 0.71x | 4.05x | $-960.00K |
| 1993 | 14.61% | 4.95% | 1.00x | 2.94x | $159.90 Million |
| 1994 | 12.54% | 5.66% | 0.90x | 2.46x | $127.80 Million |
| 1995 | 13.48% | 5.43% | 0.89x | 2.79x | $248.10 Million |
| 1996 | 17.48% | 7.56% | 0.94x | 2.47x | $644.10 Million |
| 1997 | -4.21% | -1.62% | 0.86x | 3.03x | $-1.03 Billion |
| 1998 | 6.21% | 2.52% | 0.96x | 2.56x | $-287.10 Million |
| 1999 | 13.17% | 4.44% | 0.99x | 3.01x | $178.30 Million |
| 2000 | 6.63% | 1.75% | 0.95x | 3.99x | $-148.50 Million |
| 2001 | 18.61% | 4.94% | 1.01x | 3.72x | $409.80 Million |
| 2002 | 14.61% | 4.22% | 1.05x | 3.29x | $262.80 Million |
| 2003 | 21.45% | 6.11% | 1.04x | 3.39x | $711.10 Million |
| 2004 | 28.27% | 5.30% | 1.09x | 4.87x | $805.30 Million |
| 2005 | 29.28% | 5.82% | 1.10x | 4.57x | $937.70 Million |
| 2006 | 0.00% | 4.07% | 1.08x | 0.00x | $2.17 Billion |
| 2007 | 0.00% | 3.25% | 1.12x | 0.00x | $1.93 Billion |
| 2008 | 0.00% | 2.37% | 1.17x | 0.00x | $1.70 Billion |
| 2009 | 0.00% | 3.51% | 1.25x | 0.00x | $1.95 Billion |
| 2010 | 0.00% | 3.93% | 1.29x | 0.00x | $2.40 Billion |
| 2011 | 0.00% | 7.58% | 1.21x | 0.00x | $3.29 Billion |
| 2012 | 0.00% | 4.86% | 1.18x | 0.00x | $2.57 Billion |
| 2013 | 0.00% | 4.55% | 1.19x | 0.00x | $2.38 Billion |
| 2014 | 0.00% | 5.08% | 1.18x | 0.00x | $2.66 Billion |
| 2015 | 0.00% | 5.37% | 1.21x | 0.00x | $2.89 Billion |
| 2016 | 0.00% | 6.97% | 1.23x | 0.00x | $3.62 Billion |
| 2017 | 0.00% | 5.08% | 1.19x | 0.00x | $2.90 Billion |
| 2018 | 0.00% | 8.11% | 1.19x | 0.00x | $4.28 Billion |
| 2019 | 0.00% | 6.83% | 1.14x | 0.00x | $3.79 Billion |
| 2020 | 656.29% | 7.28% | 1.09x | 83.02x | $3.70 Billion |
| 2021 | 0.00% | 11.84% | 1.16x | 0.00x | $7.05 Billion |
| 2022 | 0.00% | 9.37% | 1.15x | 0.00x | $5.92 Billion |
| 2023 | 0.00% | 8.07% | 1.16x | 0.00x | $5.42 Billion |
| 2024 | 0.00% | 8.16% | 1.19x | 0.00x | $6.01 Billion |
| 2025 | 0.00% | 8.97% | 1.25x | 0.00x | $7.39 Billion |
Industry Comparison
This section compares HCA Healthcare Inc.'s net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| HCA Healthcare Inc. (0J1R) | $-2.77 Billion | 23.67% | N/A | $81.26 Billion |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |